BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Procter & Gamble Health Ltd. Share Price

NSE
BSE

NSE : PGHL

BSE : 500126

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹6,212.00

High

₹6,380.00

Price Summary

Previous Close ₹6,244.00
Day's Range ₹6,212.00 - ₹6,380.00
Open ₹6,293.00
52 Week Range ₹4,707.00 - ₹6,739.00
Volume 12,057
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 755.90
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 3.27
Price/Earning (TTM) 31.84
TTM EPS (₹) 196.94
P/E Ratio 36.42
Book Value(₹) 19.85
PAT Margin (%) 22.78
Face Value (₹) 10.00
ROCE(%) 58.05

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 0.0 3109.9
Expenses N/A N/A
PBT 0.0 785.3
Operating profit 0.0 0.0
Net profit 0.0 611.8

Shareholding Pattern

Promoters (% Holding)

51.82%

Mutual funds (% Holding)

10.20%

Non-Institution (% Holding)

28.31%

FI/Banks/Insurance (% Holding)

3.34%

Government (% Holding)

0.00%

FII

6.20%

About Procter & Gamble Health Ltd.

Founded 1967
Managing Director Milind Thatte
NSE Symbol PGHL

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,40,793.82 1,838.35 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,78,956.35 6,752.80 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,49,819.64 4,421.70 3,140.10 - 3,140.10
Apollo Hospitals Enterprise Ltd. 1,22,170.95 8,516.00 6,696.50 - 6,696.50
Cipla Ltd. 1,09,370.14 1,353.85 1,165.70 - 1,165.70
Lupin Ltd. 1,07,536.52 2,347.65 1,836.80 - 1,836.80
Zydus Lifesciences Ltd. 1,06,822.69 1,070.60 835.50 - 835.50
Max Healthcare Institute Ltd. 1,06,672.39 1,092.00 903.00 - 903.00
Dr. Reddy's Laboratories Ltd. 1,06,133.20 1,271.55 1,148.40 - 1,148.40
Mankind Pharma Ltd. 99,835.58 2,417.35 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Jun
18
2026
EQUITY Posted on Jun 18th 2026

Procter & Gamble Health submits presentation

With reference to the intimation dated June 4, with respect to the virtual connect with analysts/ institutional investors to be held today, Thursday, June 18, 2026, at 2:30 pm (IST). Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Procter & Gamble Health has informed that it enclosed the presentation for the above meeting with analysts/ institutional investors.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
4
2026
EQUITY Posted on Jun 4th 2026

Procter & Gamble Health informs about analyst meet

Procter & Gamble Health has informed that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts interested in joining the connect are requested to complete the registration on link provided in the attached intimation by June 8, 2026. The company will share meeting link and details to the participants who have registered, separately.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Dr Reddys Laboratories informs about press release

Dr Reddys Laboratories has informed that it enclosed copies of the newspaper advertisement titled ‘Notice of the 42nd Annual General Meeting to be held through video conference, record date and final dividend information’, as published in Business Standard and Nava Telangana. This communication has also been sent via email to all the shareholders.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Dr. Agarwals Health Care informs about trading window closure

Dr. Agarwals Health Care has informed that pursuant to Dr. Agarwal’s Health Care Limited (‘the Company’) Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company shall remain closed for all the Designated Persons and their Immediate Relatives with effect from June 30, 2026. The Trading Window closure is being implemented in view of the finalization and publication of the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ending June 30, 2026. The Trading Window shall reopen after the expiry of 48 hours from the announcement of the aforesaid Financial Results by the Company, duly approved by the Board of Directors at their meeting, the details of which shall be communicated in the due course. This information can also be accessed on the website of the Company at: https://dragarwals.co.in/dr-agarwals-health-care/#corporate-announcement.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Zydus Lifesciences informs about disclosures

Zydus Lifesciences has enclosed disclosures in prescribed Form ‘C’ under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, received from Promoters, Promoters Group, Directors and their immediate relatives with respect to acceptance of Equity Shares of Re 1 each of the Company tendered under buyback through tender offer on proportionate basis.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Procter & Gamble Health Ltd. ?

The current share price of Procter & Gamble Health Ltd. is ₹6,244.00 as of 2026-06-19.

The market capitalisation of Procter & Gamble Health Ltd. is ₹10,409.97 as of 2026-06-19.

The 1-year return of Procter & Gamble Health Ltd. is 0.00% as of 2026-06-19.

The P/E ratio of Procter & Gamble Health Ltd. is 36.42 as of 2026-06-22.

The 52-week high and low of Procter & Gamble Health Ltd. are ₹6,739.00 and ₹4,707.00, respectively, as of 2026-06-19.

The dividend yield of Procter & Gamble Health Ltd. is 3.2689% as of2026-06-19.

You can buy Procter & Gamble Health Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Procter & Gamble Health Ltd. is Milind Thatte.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore